Celltrion
068270.KS
#755
Rank
S$41.40 B
Marketcap
S$189.24
Share price
1.40%
Change (1 day)
19.68%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): S$2.46

According to Celltrion 's latest financial reports the company's current EPS (TTM) is S$2.41. In 2024 the company made an earnings per share (EPS) of S$1.71 a decrease over its 2023 EPS that were of S$3.39.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S$2.4643.8%
2024S$1.71-49.57%
2023S$3.39-2.08%
2022S$3.46-11.72%
2021S$3.922.03%
2020S$3.8482.8%
2019S$2.1018.31%
2018S$1.78-36.33%
2017S$2.79161.25%
2016S$1.072.86%
2015S$1.0417.84%
2014S$0.885.87%
2013S$0.83-70.85%
2012S$2.85134.09%
2011S$1.2243.59%
2010S$0.8574.49%
2009S$0.49317.8%
2008S$0.12-71.7%
2007S$0.41